0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tourette Syndrome Treatment Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-32K7809
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Tourette Syndrome Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Tourette Syndrome Treatment Market Research Report 2025

Code: QYRE-Auto-32K7809
Report
June 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tourette Syndrome Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Tourette Syndrome Treatment Market

Tourette Syndrome Treatment Market

The global market for Tourette Syndrome Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tourette Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tourette Syndrome Treatment.
The Tourette Syndrome Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tourette Syndrome Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tourette Syndrome Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tourette Syndrome Treatment Market Report

Report Metric Details
Report Name Tourette Syndrome Treatment Market
CAGR 5%
Segment by Type
Segment by Application
  • Children
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Mylan NV, Otsuka Holdings Co. Ltd., Sanofi S.A., Pfizer Inc., Sun Pharmaceutical Industries Ltd, Neurocrine Biosciences, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tourette Syndrome Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tourette Syndrome Treatment Market report?

Ans: The main players in the Tourette Syndrome Treatment Market are AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Mylan NV, Otsuka Holdings Co. Ltd., Sanofi S.A., Pfizer Inc., Sun Pharmaceutical Industries Ltd, Neurocrine Biosciences, Inc., Novartis AG, Teva Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Tourette Syndrome Treatment Market report?

Ans: The Applications covered in the Tourette Syndrome Treatment Market report are Children, Adult

What are the Type segmentation covered in the Tourette Syndrome Treatment Market report?

Ans: The Types covered in the Tourette Syndrome Treatment Market report are Antipsychotics, Non Antipsychotics

Recommended Reports

Neuropsychiatric Disorders

Syndrome Treatments

Neuromuscular Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tourette Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antipsychotics
1.2.3 Non Antipsychotics
1.3 Market by Application
1.3.1 Global Tourette Syndrome Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tourette Syndrome Treatment Market Perspective (2020-2031)
2.2 Global Tourette Syndrome Treatment Growth Trends by Region
2.2.1 Global Tourette Syndrome Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tourette Syndrome Treatment Historic Market Size by Region (2020-2025)
2.2.3 Tourette Syndrome Treatment Forecasted Market Size by Region (2026-2031)
2.3 Tourette Syndrome Treatment Market Dynamics
2.3.1 Tourette Syndrome Treatment Industry Trends
2.3.2 Tourette Syndrome Treatment Market Drivers
2.3.3 Tourette Syndrome Treatment Market Challenges
2.3.4 Tourette Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tourette Syndrome Treatment Players by Revenue
3.1.1 Global Top Tourette Syndrome Treatment Players by Revenue (2020-2025)
3.1.2 Global Tourette Syndrome Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Tourette Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tourette Syndrome Treatment Revenue
3.4 Global Tourette Syndrome Treatment Market Concentration Ratio
3.4.1 Global Tourette Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tourette Syndrome Treatment Revenue in 2024
3.5 Global Key Players of Tourette Syndrome Treatment Head office and Area Served
3.6 Global Key Players of Tourette Syndrome Treatment, Product and Application
3.7 Global Key Players of Tourette Syndrome Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tourette Syndrome Treatment Breakdown Data by Type
4.1 Global Tourette Syndrome Treatment Historic Market Size by Type (2020-2025)
4.2 Global Tourette Syndrome Treatment Forecasted Market Size by Type (2026-2031)
5 Tourette Syndrome Treatment Breakdown Data by Application
5.1 Global Tourette Syndrome Treatment Historic Market Size by Application (2020-2025)
5.2 Global Tourette Syndrome Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tourette Syndrome Treatment Market Size (2020-2031)
6.2 North America Tourette Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tourette Syndrome Treatment Market Size by Country (2020-2025)
6.4 North America Tourette Syndrome Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tourette Syndrome Treatment Market Size (2020-2031)
7.2 Europe Tourette Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tourette Syndrome Treatment Market Size by Country (2020-2025)
7.4 Europe Tourette Syndrome Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tourette Syndrome Treatment Market Size (2020-2031)
8.2 Asia-Pacific Tourette Syndrome Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tourette Syndrome Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Tourette Syndrome Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tourette Syndrome Treatment Market Size (2020-2031)
9.2 Latin America Tourette Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tourette Syndrome Treatment Market Size by Country (2020-2025)
9.4 Latin America Tourette Syndrome Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tourette Syndrome Treatment Market Size (2020-2031)
10.2 Middle East & Africa Tourette Syndrome Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tourette Syndrome Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Tourette Syndrome Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Tourette Syndrome Treatment Introduction
11.1.4 AstraZeneca Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Details
11.2.2 Boehringer Ingelheim International GmbH Business Overview
11.2.3 Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Introduction
11.2.4 Boehringer Ingelheim International GmbH Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.2.5 Boehringer Ingelheim International GmbH Recent Development
11.3 Eli Lilly and Co.
11.3.1 Eli Lilly and Co. Company Details
11.3.2 Eli Lilly and Co. Business Overview
11.3.3 Eli Lilly and Co. Tourette Syndrome Treatment Introduction
11.3.4 Eli Lilly and Co. Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.3.5 Eli Lilly and Co. Recent Development
11.4 Mylan NV
11.4.1 Mylan NV Company Details
11.4.2 Mylan NV Business Overview
11.4.3 Mylan NV Tourette Syndrome Treatment Introduction
11.4.4 Mylan NV Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.4.5 Mylan NV Recent Development
11.5 Otsuka Holdings Co. Ltd.
11.5.1 Otsuka Holdings Co. Ltd. Company Details
11.5.2 Otsuka Holdings Co. Ltd. Business Overview
11.5.3 Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Introduction
11.5.4 Otsuka Holdings Co. Ltd. Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.5.5 Otsuka Holdings Co. Ltd. Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Details
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Tourette Syndrome Treatment Introduction
11.6.4 Sanofi S.A. Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.6.5 Sanofi S.A. Recent Development
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Details
11.7.2 Pfizer Inc. Business Overview
11.7.3 Pfizer Inc. Tourette Syndrome Treatment Introduction
11.7.4 Pfizer Inc. Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.7.5 Pfizer Inc. Recent Development
11.8 Sun Pharmaceutical Industries Ltd
11.8.1 Sun Pharmaceutical Industries Ltd Company Details
11.8.2 Sun Pharmaceutical Industries Ltd Business Overview
11.8.3 Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Introduction
11.8.4 Sun Pharmaceutical Industries Ltd Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.8.5 Sun Pharmaceutical Industries Ltd Recent Development
11.9 Neurocrine Biosciences, Inc.
11.9.1 Neurocrine Biosciences, Inc. Company Details
11.9.2 Neurocrine Biosciences, Inc. Business Overview
11.9.3 Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Introduction
11.9.4 Neurocrine Biosciences, Inc. Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.9.5 Neurocrine Biosciences, Inc. Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Tourette Syndrome Treatment Introduction
11.10.4 Novartis AG Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.10.5 Novartis AG Recent Development
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Details
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Tourette Syndrome Treatment Business (2020-2025)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Tourette Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antipsychotics
 Table 3. Key Players of Non Antipsychotics
 Table 4. Global Tourette Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Tourette Syndrome Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Tourette Syndrome Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Tourette Syndrome Treatment Market Share by Region (2020-2025)
 Table 8. Global Tourette Syndrome Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Tourette Syndrome Treatment Market Share by Region (2026-2031)
 Table 10. Tourette Syndrome Treatment Market Trends
 Table 11. Tourette Syndrome Treatment Market Drivers
 Table 12. Tourette Syndrome Treatment Market Challenges
 Table 13. Tourette Syndrome Treatment Market Restraints
 Table 14. Global Tourette Syndrome Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Tourette Syndrome Treatment Market Share by Players (2020-2025)
 Table 16. Global Top Tourette Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Treatment as of 2024)
 Table 17. Ranking of Global Top Tourette Syndrome Treatment Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Tourette Syndrome Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Tourette Syndrome Treatment, Headquarters and Area Served
 Table 20. Global Key Players of Tourette Syndrome Treatment, Product and Application
 Table 21. Global Key Players of Tourette Syndrome Treatment, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Tourette Syndrome Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Tourette Syndrome Treatment Revenue Market Share by Type (2020-2025)
 Table 25. Global Tourette Syndrome Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Tourette Syndrome Treatment Revenue Market Share by Type (2026-2031)
 Table 27. Global Tourette Syndrome Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Tourette Syndrome Treatment Revenue Market Share by Application (2020-2025)
 Table 29. Global Tourette Syndrome Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Tourette Syndrome Treatment Revenue Market Share by Application (2026-2031)
 Table 31. North America Tourette Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Tourette Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Tourette Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Tourette Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Tourette Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Tourette Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Tourette Syndrome Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Tourette Syndrome Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Tourette Syndrome Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tourette Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Tourette Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Tourette Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Tourette Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Tourette Syndrome Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Tourette Syndrome Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AstraZeneca Company Details
 Table 47. AstraZeneca Business Overview
 Table 48. AstraZeneca Tourette Syndrome Treatment Product
 Table 49. AstraZeneca Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 50. AstraZeneca Recent Development
 Table 51. Boehringer Ingelheim International GmbH Company Details
 Table 52. Boehringer Ingelheim International GmbH Business Overview
 Table 53. Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Product
 Table 54. Boehringer Ingelheim International GmbH Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 55. Boehringer Ingelheim International GmbH Recent Development
 Table 56. Eli Lilly and Co. Company Details
 Table 57. Eli Lilly and Co. Business Overview
 Table 58. Eli Lilly and Co. Tourette Syndrome Treatment Product
 Table 59. Eli Lilly and Co. Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 60. Eli Lilly and Co. Recent Development
 Table 61. Mylan NV Company Details
 Table 62. Mylan NV Business Overview
 Table 63. Mylan NV Tourette Syndrome Treatment Product
 Table 64. Mylan NV Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 65. Mylan NV Recent Development
 Table 66. Otsuka Holdings Co. Ltd. Company Details
 Table 67. Otsuka Holdings Co. Ltd. Business Overview
 Table 68. Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Product
 Table 69. Otsuka Holdings Co. Ltd. Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 70. Otsuka Holdings Co. Ltd. Recent Development
 Table 71. Sanofi S.A. Company Details
 Table 72. Sanofi S.A. Business Overview
 Table 73. Sanofi S.A. Tourette Syndrome Treatment Product
 Table 74. Sanofi S.A. Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 75. Sanofi S.A. Recent Development
 Table 76. Pfizer Inc. Company Details
 Table 77. Pfizer Inc. Business Overview
 Table 78. Pfizer Inc. Tourette Syndrome Treatment Product
 Table 79. Pfizer Inc. Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 80. Pfizer Inc. Recent Development
 Table 81. Sun Pharmaceutical Industries Ltd Company Details
 Table 82. Sun Pharmaceutical Industries Ltd Business Overview
 Table 83. Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Product
 Table 84. Sun Pharmaceutical Industries Ltd Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 85. Sun Pharmaceutical Industries Ltd Recent Development
 Table 86. Neurocrine Biosciences, Inc. Company Details
 Table 87. Neurocrine Biosciences, Inc. Business Overview
 Table 88. Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Product
 Table 89. Neurocrine Biosciences, Inc. Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 90. Neurocrine Biosciences, Inc. Recent Development
 Table 91. Novartis AG Company Details
 Table 92. Novartis AG Business Overview
 Table 93. Novartis AG Tourette Syndrome Treatment Product
 Table 94. Novartis AG Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 95. Novartis AG Recent Development
 Table 96. Teva Pharmaceutical Industries Ltd. Company Details
 Table 97. Teva Pharmaceutical Industries Ltd. Business Overview
 Table 98. Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Product
 Table 99. Teva Pharmaceutical Industries Ltd. Revenue in Tourette Syndrome Treatment Business (2020-2025) & (US$ Million)
 Table 100. Teva Pharmaceutical Industries Ltd. Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Tourette Syndrome Treatment Picture
 Figure 2. Global Tourette Syndrome Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tourette Syndrome Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Antipsychotics Features
 Figure 5. Non Antipsychotics Features
 Figure 6. Global Tourette Syndrome Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tourette Syndrome Treatment Market Share by Application: 2024 VS 2031
 Figure 8. Children Case Studies
 Figure 9. Adult Case Studies
 Figure 10. Tourette Syndrome Treatment Report Years Considered
 Figure 11. Global Tourette Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Tourette Syndrome Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Tourette Syndrome Treatment Market Share by Region: 2024 VS 2031
 Figure 14. Global Tourette Syndrome Treatment Market Share by Players in 2024
 Figure 15. Global Top Tourette Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tourette Syndrome Treatment as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Tourette Syndrome Treatment Revenue in 2024
 Figure 17. North America Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Tourette Syndrome Treatment Market Share by Country (2020-2031)
 Figure 19. United States Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Tourette Syndrome Treatment Market Share by Country (2020-2031)
 Figure 23. Germany Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Tourette Syndrome Treatment Market Share by Region (2020-2031)
 Figure 31. China Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Tourette Syndrome Treatment Market Share by Country (2020-2031)
 Figure 39. Mexico Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Tourette Syndrome Treatment Market Share by Country (2020-2031)
 Figure 43. Turkey Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Tourette Syndrome Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. AstraZeneca Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 47. Boehringer Ingelheim International GmbH Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 48. Eli Lilly and Co. Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 49. Mylan NV Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 50. Otsuka Holdings Co. Ltd. Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 51. Sanofi S.A. Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 52. Pfizer Inc. Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 53. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 54. Neurocrine Biosciences, Inc. Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 55. Novartis AG Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Tourette Syndrome Treatment Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13Z8760
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Intracranial Pressure (ICP) Monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37L4006
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Brain Disease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12P6151
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3X6389
Mon Sep 08 00:00:00 UTC 2025

Add to Cart